Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa-/-) mice were generated by gene targeting and monitored for eight months. C1qa-/- mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Casciola-Rosen, L., Rosen, A., Petri, M., & Schlissel, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1624 · Cited by 482
Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., & Savill, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117565 · Cited by 404
LeFeber, W. P., Norris, D. A., Ryan, S. R., Huff, J. C., Lee, L. A., Kubo, M., Boyce, S. T., Kotzin, B. L., & Weston, W. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111569 · Cited by 335
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Self-citationNovel packages of viral and self-antigens are generated during apoptosis.
Rosen, A., Casciola-Rosen, L., & Ahearn, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1557 · Cited by 246
Hereditary C1q deficiency and systemic lupus erythematosus
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068955 · Cited by 207
Self-citationGolan, T. D., Elkon, K. B., Gharavi, A. E., & Krueger, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115922 · Cited by 165
Subnucleosome structures as substrates in enzyme-linked immunosorbent assays
Burlingame, R. W., & Rubin, R. L. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90380-e · Cited by 124
Cited by
Items 701–800 of 1,000
Leukocytes in glomerular injury
Holdsworth, S. R., & Tipping, P. G. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0097-9 · Cited by 43
Mechanisms of Disease: the complement system in renal injury—new ways of looking at an old foe
Brown, K. M., Sacks, S. H., & Sheerin, N. (2007) · Nature Reviews Nephrology · doi:10.1038/ncpneph0465 · Cited by 45
“Mice with an engineered deficiency in C1q also develop proliferative glomerulonephritis and increased autoantibody titers”
BackgroundGenetic susceptibility to lupus nephritis
Tsao, B. P. (1998) · Lupus · doi:10.1191/096120398678920695 · Cited by 44
Lauwerys, B. R., & Wakeland, E. K. (2005) · Lupus · doi:10.1191/0961203305lu2052oa · Cited by 42
Lupus Nephritis in Children: Novel Perspectives
Pennesi, M., & Benvenuto, S. (2023) · Medicina · doi:10.3390/medicina59101841 · Cited by 50
“Complement defects include mutations in the C1q gene with about 90% penetrance and severe disease course, C2 deficiency, which is the most common, or C4 deficiency [38–40].”
BackgroundAnimal Models of Molecular Pathology
Sang, A. L., Yin, Y., Zheng, Y.-Y., & Morel, L. M. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00010-x · Cited by 46
Complement regulatory proteins and autoimmunity
Song, W.-C. (2006) · Autoimmunity · doi:10.1080/08916930600739647 · Cited by 40
“[5] Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ.”
BackgroundJiang, C., Zhao, M., & Diaz, M. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02882.x · Cited by 42
Prabagar, M. G., Do, Y., Ryu, S. H., Park, J.-Y., Choi, H.-J., Choi, W.-S., Yun, T. J., Moon, J. J., Choi, I.-S., Ko, K., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.160 · Cited by 50
Liphaus, B. L., & Kiss, M. H. B. (2010) · Clinics · doi:10.1590/s1807-59322010000300014 · Cited by 45
“This opsonization will further accelerate their uptake by phagocytes and contribute to additional anti-inflammatory responses.49 The former observations can explain why other complement component deficiencies have also been associated with lupus.13 Botto et al.55 demonstrated impaired clearance of apoptotic cells and…”
BackgroundInterleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus
Lech, M., Kantner, C., Kulkarni, O. P., Ryu, M., Vlasova, E., Heesemann, J., Anz, D., Endres, S., Kobayashi, K. S., Flavell, R. A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.155515 · Cited by 45
WEISENBURGER, T. H., von Neubeck, B., Schneider, A. M., Ebert, N., Schreyer, D., Acs, A., & Winkler, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01551 · Cited by 42
“Homozygous mutations in the C1q genes are responsible for SLE or SLE-like disease (7) and C1q-deficient mice accumulate apoptotic cells in several tissues and develop anti-DNA autoantibodies and SLE in certain genetic backgrounds but not in the C57BL/6 background (8, 9).”
Fu, M., Fan, P.-S., Li, W., Li, C., Xing, Y., An, J.-G., Wang, G., Fan, X., Gao, T., Liu, Y., et al. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0581-z · Cited by 42
“Mice deficient in MFG-E8 or C1q develop a lupus-like autoimmune phenotype, which is accompanied by diminished clearance of apoptotic cells in vivo [6, 7].”
BackgroundAutoimmunity in systemic lupus erythematosus: Integrating genes and biology
Krishnan, S. K., Chowdhury, B., & Tsokos, G. C. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.011 · Cited by 48
Innate recognition systems in insect immunity and development: new approaches in
Franc, N. C., & White, K. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00304-x · Cited by 53
Recognizing death: liver phagocytosis of apoptotic cells
Dini, L. (2009) · European Journal of Histochemistry · doi:10.4081/ejh.2000.1585 · Cited by 42
Systemic lupus erythematosus diagnostics in the ‘omics’ era
Arriens, C., & Mohan, C. (2013) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.13.59 · Cited by 45
C1q as an autocrine and paracrine regulator of cellular functions
Ghebrehiwet, B., Hosszu, K. H., & Peerschke, E. I. B. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.11.003 · Cited by 41
Tissue Dependent Role of PTX3 During Ischemia-Reperfusion Injury
de Oliveira, T. H. C., Souza, D. G., Teixeira, M. M., & Amaral, F. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01461 · Cited by 43
“Furthermore, deficiencies of C1q is associated with development of systemic erythematosus lupus (SLE) and accumulation of apoptotic cells in renal glomeruli, which emphasizes the importance of C1q in the clearance of cellular debris (56).”
BackgroundThanei, S., Vanhecke, D., & Trendelenburg, M. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.06.014 · Cited by 43
Dynamic control of the complement system by modulated expression of regulatory proteins
Thurman, J. M., & Renner, B. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.173 · Cited by 41
“This is evident in C1q-deficient mice, where there is an increase in prevalent apoptotic cells.(28) For complement to be selectively activated on apoptotic cells, the surface expression of some complement regulatory proteins on these cells decreases relative to expression in healthy cells.”
BackgroundInflammation and the apopto-phagocytic system
Majai, G. E., Petrovski, G., & Fésüs, L. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.11.016 · Cited by 41
Garabuczi, É., Sarang, Z., & Szondy, Z. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.12.014 · Cited by 41
Interferon regulatory factors: critical mediators of human lupus
Jensen, M. A., & Niewold, T. B. (2014) · Translational research · doi:10.1016/j.trsl.2014.10.002 · Cited by 42
Stuart, L. M., & Hughes, J. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.5.697 · Cited by 41
Dendritic cells and complement: at the cross road of innate and adaptive immunity
Castellano, G., Woltman, A. M., Schena, F. P., Roos, A., Daha, M. R., & van Kooten, C. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.018 · Cited by 47
Bijl, M., Bootsma, H., van der Geld, Y., Limburg, P. C., Kallenberg, C. G. M., & van Rijswijk, M. H. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2002.004796 · Cited by 41
“11 In favour of the above hypothesis is the presence of apoptotic debris in the glomeruli of affected animals.”
BackgroundPhenotypes of complement knockouts
Holers, V. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80298-2 · Cited by 41
Glomerular cell apoptosis in human lupus nephritis
Wada, J., Kashihara, N., Makino, H., Sugiyama, H., Yamasaki, Y., & Maeshima, Y. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0827-x · Cited by 41
“Indeed, a recent report has demonstrated that C1q-deficient mice develop glomerulonephritis accompanied by multiple apoptotic bodies [6].”
BackgroundThe Immune Response to Apoptotic Cells
Mevorach, D. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07933.x · Cited by 44
Wu, Y., Brookshire, B., Verani, R., Arnett, F., & Yu, C. (2011) · Lupus · doi:10.1177/0961203311404914 · Cited by 40
Dahlke, K., Wrann, C. D., Sommerfeld, O., Soßdorf, M., Recknagel, P., Sachse, S., Winter, S. W., Klos, A., Stahl, G. L., Xu, Y., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002741 · Cited by 40
Complement is dispensable for neurodegeneration in Niemann-Pick disease type C
Lopez, M. E., Klein, A. D., & Scott, M. P. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-216 · Cited by 41
“Npc1 mice were derived as previously reported [17] and crossed with C1qa [24] or C3 [25] knockout mice obtained at Stanford University [3].”
MethodManagement of Glaucoma As a Neurodegenerative Disease
Jutley, G., Luk, S. M. H., Dehabadi, M. H., & Cordeiro, M. F. (2017) · Neurodegenerative Disease Management · doi:10.2217/nmt-2017-0004 · Cited by 43
“The classic complement system is initiated by C1q [140].”
van Kooten, C., Fiore, N., Trouw, L. A., Csomor, E., Xu, W., Castellano, G., Daha, M. R., & Gelderman, K. A. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.015 · Cited by 44
Troldborg, A., Thiel, S., Jensen, L., Hansen, S., Laska, M. J., Deleuran, B. W., Jensenius, J. C., & Stengaard‐Pedersen, K. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12678 · Cited by 43
Kravitz, M. S., & Shoenfeld, Y. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0290 · Cited by 43
“These glomerular changes were also seen in mice without notable renal dysfunction”
BackgroundCelik, I., Stover, C. M., Botto, M., Thiel, S., Tzima, S., Künkel, D., Walport, M. J., Lorenz, W., & Schwaeble, W. (2001) · Infection and Immunity · doi:10.1128/iai.69.12.7304-7309.2001 · Cited by 40
“In order to study the physiological and pathophysiological consequences of selective complement deficiency, mouse strains deficient in the expression of the complement proteins C1q and factor B and C2 were generated by gene-specific targeting as previously reported (3, 33).”
BackgroundMethodSelf-citationMacrophages regulate gastrointestinal motility through complement component 1q
Pendse, M., Selle, H. D., Vo, N., Quinn, G. M., Dende, C., Li, Y., Salinas, C. N., Srinivasan, T., Propheter, D. C., Crofts, A. A., et al. (2023) · eLife · doi:10.7554/elife.78558 · Cited by 39
“Given that C1q can opsonize dying host cells (Botto et al., 1998; Korb and Ahearn, 1997), C1q could regulate enteric nervous system function by tagging apoptotic neurons for elimination.”
BackgroundComplement activation and regulation in rheumatic disease
Dijkstra, D. J., Joeloemsingh, J. V., Bajema, I. M., & Trouw, L. A. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101339 · Cited by 39
Revisiting the complement system in systemic lupus erythematosus
Sharma, M., Vignesh, P., Tiewsoh, K., & Rawat, A. K. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1745063 · Cited by 40
“Out of these, 84% had cutaneous lupus, 30% glomerulonephritis, 19% cerebral disease, 22% oral ulcers, and 16% arthralgia [19].”
BackgroundComplement as a Therapeutic Target in Systemic Autoimmune Diseases
Galindo-Izquierdo, M., & Pablos, J. L. (2021) · Cells · doi:10.3390/cells10010148 · Cited by 40
Roles of the Alternative Complement Pathway and C1q during Innate Immunity to Streptococcus pyogenes
Yuste, J., Ali, S., Sriskandan, S., Hyams, C. J., Botto, M., & Brown, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6112 · Cited by 43
“The following immune-deficient mice backcrossed to the C57BL/6 background for 10 generations were used in this study: C1qa / (C1q deficient, no classical pathway activity) (20), Bf / (factor B deficient, no alternative pathway activity) (21), C3 / (C3 deficient, no effective complement activity) (5), C1qa / .”
MethodSelf-citationGalvan, M. D., Hulsebus, H. J., Heitker, T., Zeng, E., & Bohlson, S. S. (2014) · Journal of Innate Immunity · doi:10.1159/000363295 · Cited by 43
Role of Complement in the Development of Autoimmunity
Boackle, S. A., & Holers, V. M. (2002) · KARGER eBooks · doi:10.1159/000066860 · Cited by 39
Complement C1q expression induced by Aβ in rat hippocampal organotypic slice cultures
Fan, R., & Tenner, A. J. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.023 · Cited by 34
Gomes, M. T., Palasiewicz, K., Gadiyar, V., Lahey, K. C., Calianese, D. C., Birge, R. B., & Ucker, D. S. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102034 · Cited by 41
11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Chapman, K. E., & Seckl, J. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9504-9 · Cited by 47
“Failure of macrophages to rapidly phagocytose apoptotic neutrophils allows them to undergo secondary necrosis, provoking macrophage release of proinflammatory mediators and prolonging the inflammatory response [136, 137].”
BackgroundPrix Fixe: Efferocytosis as a Four-Course Meal
Martinez, J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_467 · Cited by 42
“SLE patients also contain elevated levels of DNA or nucleosomes in the circulation, as well as autoantibodies that are specific for nuclear or other “self” components (Rumore and Steinman 1990).”
BackgroundInfluentialFehr, E.-M., Spoerl, S., Heyder, P., i, M. H., Bekeredjian‐Ding, I., Blank, N., Lorenz, H., & Schiller, M. R. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.08.003 · Cited by 41
Sadallah, S., Eken, C., & Schifferli, J. A. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-010-0232-x · Cited by 38
“Together with this rapid clearance, the adherence of ectosomes to erythrocytes may prevent binding to endothelial cells, thus avoiding harmful fixation in tissues, for instance glomeruli, as shown for apoptotic bodies and immune complexes [43, 45].”
BackgroundChi, S., Yu, Y., Shi, J., Zhang, Y., Yang, J., Yang, L., & Liu, X. (2015) · Disease Markers · doi:10.1155/2015/450351 · Cited by 38
Serum-Derived Plasminogen Is Activated by Apoptotic Cells and Promotes Their Phagocytic Clearance
Rosenwald, M., Koppe, U., Keppeler, H., Sauer, G., Hennel, R., Ernst, A., Blume, K., Peter, C., i, M. H., Belka, C., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200922 · Cited by 39
Naturally Occurring Autoantibodies to Apoptotic Cells
Elkon, K. B., & Silverman, G. J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3461-0_2 · Cited by 41
Heidari, Y., Bygrave, A. E., Rigby, R. J., Rose, K. L., Walport, M. J., Cook, H. T., Vyse, T. J., & Botto, M. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364335 · Cited by 38
Self-citationMolina, H. D. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00113-3 · Cited by 38
Kaul, M., & Loos, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02592-3 · Cited by 38
Self-citationRole of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells
Ronchetti, A. B., Iezzi, G., Crosti, M., Garancini, M. P., Protti, M. P., & Bellone, M. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.2.247 · Cited by 38
“the number of apoptotic cells overcomes the scavenger potential of phagocytes, because of an excess of apoptotic cells or a defect in the clearance of dying cells [32], immature DC are possibly recruited, with processing of the antigens contained in the apoptotic cells and presentation in the secondary lymphoid tissue…”
BackgroundCarroll, M. C., & Janeway, C. A. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80002-8 · Cited by 38
Novel C1q receptor-mediated signaling controls neural stem cell behavior and neurorepair
Benavente, F., Piltti, K. M., Hooshmand, M. J., Nava, A. A., Lakatos, A., Feld, B. G., Creasman, D. A., Gershon, P. D., & Anderson, A. J. (2020) · eLife · doi:10.7554/elife.55732 · Cited by 38
“In both cases, these activities are independent of complement cascade activation but remain consistent with the recognition functions of C1q in the immune system (Botto et al., 1998; Mevorach et al., 1998; Nauta et al., 2002).”
BackgroundDeficiencies and excessive human complement system activation in disorders of multifarious etiology.
Tichaczek−Goska, D. (2012) · PubMed · Cited by 45
Suen, J., Chuang, Y., Tsai, B., Yau, P. M., & Chiang, B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20520 · Cited by 37
Apoptotic cell and phagocyte interplay: recognition and consequences in different cell systems
Moreira, M. E. C., & Barcinski, M. A. (2004) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652004000100009 · Cited by 46
“Indeed, there have been few descriptions of defective clearance of apoptotic cells in vivo that corroborate in vitro studies (Botto et al. 1998, Taylor et al. 2000, Hamon et al. 2000, Scott et al. 2001, Teder et al. 2002, Vandivier et al. 2002).”
BackgroundTaylor, P. R., Seixas, E., Walport, M. J., Langhorne, J., & Botto, M. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3853-3859.2001 · Cited by 43
Self-citationSule, S. D., Rosen, A., Petri, M., Akhter, E., & Andrade, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017495 · Cited by 43
Jiang, H. X., He, P., Xie, J., Staufenbiel, M., Li, R., & Shen, Y. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu206 · Cited by 40
“TNFRII knockout (TNFRII) mice were of C57BL/6 background, constructed as previously reported (49).”
MethodPhotosensitivity in Rheumatic Diseases
Werth, V. P., Bashir, M. M., & Zhang, W. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.00839.x · Cited by 37
Defects in the disposal of dying cells lead to autoimmunity
Gaipl, U. S., Franz, S., Voll, R. E., Sheriff, A., Kalden, J. R., & i, M. H. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0016-1 · Cited by 47
Disposal of dying cells: A balancing act between infection and autoimmunity
Gaipl, U. S., Brunner, J., Beyer, T. D., Voll, R. E., Kalden, J. R., & i, M. H. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10744 · Cited by 38
Qian, Y., Conway, K. L., Lu, X., Seitz, H., Matsushima, G. K., & Clarke, S. H. (2006) · Blood · doi:10.1182/blood-2005-12-006858 · Cited by 36
Complement System in Dermatological Diseases – Fire Under the Skin
Palianus, J., & Meri, S. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00003 · Cited by 51
“Animal studies have indicated that 25% of mice with homozygous C1q deficiency also develop end-stage renal disease (33).”
BackgroundDendritic cell function in lupus: Independent contributors or victims of aberrant immune regulation
Kis‐Tóth, K., & Tsokos, G. C. (2010) · Autoimmunity · doi:10.3109/08916930903214041 · Cited by 36
“[107] Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ.”
BackgroundKidney Involvement in Hypocomplementemic Urticarial Vasculitis Syndrome—A Case-Based Review
Ion, O. G., Obrișcă, B., Ismail, G., Sorohan, B. M., Bălănică, S., Mircescu, G., & Sinescu, I. C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072131 · Cited by 36
Expression and Function of C1q Receptors and C1q Binding Proteins at the Cell Surface
Ghiran, I. C., Tyagi, S.-R., Klickstein, L. B., & Nicholson-Weller, A. (2002) · Immunobiology · doi:10.1078/0171-2985-00142 · Cited by 36
Grönwall, C., Chen, Y., Vas, J., Khanna, S., Thiel, S., Corr, M., Kono, D. H., & Silverman, G. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211868109 · Cited by 36
Rutemark, C., Alicot, E. M., Bergman, A. A., Ma, M., Getahun, A., Ellmerich, S., Carroll, M. C., & Heyman, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109831108 · Cited by 36
“C1qA mice (57) were obtained from Marina Botto (Imperial College London, United Kingdom), and SAP (58) and CRP (59) mice were obtained from Mark Pepys (Imperial College London, United Kingdom).”
MethodMarginal Zone B Cell Physiology and Disease
Carvalho, T. L., & Kearney, J. F. (2004) · KARGER eBooks · doi:10.1159/000082100 · Cited by 36
Cell surface expression of C1qRP/CD93 is stabilized by O‐glycosylation
Park, M., & Tenner, A. J. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10332 · Cited by 40
“Interestingly, C1q may also have a role in the rapid phagocytosis of apoptotic cells, as such cells are found to accumulate in C1q knockout mice and autoantibodies to cellular components are found in significant levels in these mice as they mature to adults (Botto et al., 1998).”
BackgroundBurn Injury Reveals Altered Phenotype in Mannan-Binding Lectin-Deficient Mice
Møller-Kristensen, M., Hamblin, M. R., Thiel, S., Jensenius, J. C., & Takahashi, K. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700748 · Cited by 36
“We also acknowledge Marina Botto for providing us C1q null mice.”
MethodInfluentialFerry, H., Potter, P. K., Crockford, T. L., Nijnik, A., Ehrenstein, M. R., Walport, M. J., Botto, M., & Cornall, R. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2916 · Cited by 42
“ized by multiple apoptotic bodies (15).”
BackgroundMethodSelf-citationCurrent advances in the human lupus genetics
Shen, N., & Tsao, B. P. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0014-3 · Cited by 37
“C1q-deficient (C1qa-/-) mice have impaired clearance of apoptotic bodies and develop lupus-like disease characterized by high titers of antinuclear antibodies production and proliferative glomerulonephritis [ 8 ,9].”
BackgroundUse of complement inhibitors in tissue injury
Quigg, R. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02386-9 · Cited by 36
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned
Jones, S. A., & Morand, E. F. (2024) · Drugs · doi:10.1007/s40265-024-02043-2 · Cited by 38
Hillian, A. D., McMullen, M. R., Sebastian, B. M., Rowchowdhury, S., Kashyap, S. R., Schauer, P. R., Kirwan, J. P., Feldstein, A. E., & Nagy, L. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.465674 · Cited by 35
Role of collectins and complement protein C1q in pregnancy and parturition
Madhukaran, S. P., Alhamlan, F. S., Kale, K., Vatish, M., Madan, T., & Kishore, U. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.06.002 · Cited by 37
Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis
Ma, H., Liu, C., Shi, B., Zhang, Z., Feng, R., Guo, M., Lu, L., Shi, S., Gao, X., Chen, W., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.034 · Cited by 35
“Additionally, preclinical studies and clinical investigations have shown that C1q knockout mice or individuals with defective C1q genes developed SLE-like autoimmune diseases [12, 13], and that C3 deficiency aggravated proteinuria in lupus”
BackgroundMolecular analysis of a novel hereditary C3 deficiency with systemic lupus erythematosus
Tsukamoto, H., Horiuchi, T., Kokuba, H., NAGAE, S., Nishizaka, H., Sawabe, T., Harashima, S., Himeji, D., Koyama, T., Otsuka, J., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.159 · Cited by 35
“[29].”
van Montfoort, N., de Jong, J. M. H., Schuurhuis, D. H., van der Voort, E. I. H., Camps, M. G. M., Huizinga, T. W. J., van Kooten, C., Daha, M. R., Verbeek, J. S., OSSENDORP, F. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7581 · Cited by 35
Removal of dying cells and systemic lupus erythematosus
Grossmayer, G. E., Munoz, L. E., Gaipl, U. S., Franz, S., Sheriff, A., Voll, R. E., Kalden, J. R., & i, M. H. (2005) · Modern Rheumatology · doi:10.1007/s10165-005-0430-x · Cited by 35
Yasutomo, K. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg081 · Cited by 35
Apoptosis, cross-presentation, and the fate of the antigen specific immune response
Bellone, M. (2000) · APOPTOSIS · doi:10.1023/a:1009671105696 · Cited by 35
Cytokine inhibition as a strategy for treating systemic lupus erythematosus
Clark, D. N., Markham, J. L., Sloan, C. S., & Poole, B. D. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.11.001 · Cited by 38
The role of nucleotides in apoptotic cell clearance: implications for disease pathogenesis
Chekeni, F. B., & Ravichandran, K. S. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0673-7 · Cited by 42
“Hindering clearance in vivo has also been shown to induce the development of autoantibodies and in some cases autoimmune disease-like phenotypes [28, 31, 40, 69, 70, 72, 73, 80].”
BackgroundLi, Q., Li, Y. X., Stahl, G. L., Thurman, J. M., He, Y., & Tong, H. H. (2011) · Infection and Immunity · doi:10.1128/iai.00168-11 · Cited by 34
“C57BL/6 mice homozygous for combined gene deficiencies of factor B and C2 (Bf/C2 / ), C1qa (C1qa / ), and factor B (Bf / ) were generated as previously described (3, 15, 26).”
MethodRole of Complement in Immune Regulation and Its Exploitation by Virus
Cummings, K. L., Waggoner, S. N., Tacke, R., & Hahn, Y. S. (2007) · Viral Immunology · doi:10.1089/vim.2007.0061 · Cited by 34
“In addition, in the absence of C1q or C3, antigen uptake by phagocytes is suboptimal and results in failed DC maturation as well as poor T-cell stimulatory capacity (11,13,78,135,174).”
Plawecki, M., Lheritier, E., Clavarino, G., Jourde‐Chiche, N., Ouili, S., Paul, S., Gout, E., Sarrot-Reynauld, F., Bardin, N., Boëlle, P., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160879 · Cited by 35
“Mice deficient for C1q, the recognition protein of the classical complement pathway, are predisposed to SLE-like diseases [10] and human studies report that hereditary homozygous deficiencies of C1q are strongly associated with susceptibility to SLE, with a defect in apoptotic cells uptake by macrophages in SLE patien…”
BackgroundMADERNA, P., & Godson, C. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.004 · Cited by 38
Zhou, Z., Mangahas, P. M., & Yu, X. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)63004-3 · Cited by 36
Necrotizing infundibulo-hypophysitis: an entity too rare to be true?
Gutenberg, A., Caturegli, P., Metz, I., Martínez, R., Mohr, A., Brück, W., & Rohde, V. (2011) · Pituitary · doi:10.1007/s11102-011-0307-2 · Cited by 33
“The rearranged cell surface allows the binding of numerous factors such as the complement factor C1q [19] and the milk factor globule epidermal growth factor 8 [20] that suppress inflammation and promote the engulfment by macrophages and dendritic cells [21].”
BackgroundComplement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice
Chen, K., Deng, Y., Shang, S., Tang, L., Li, Q., Bai, X., & Chen, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113433 · Cited by 34
Metadata
- Authors
- Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J.
- Affiliations
- Imperial College London (GB)
- Institute of Medical Microbiology and Hygiene (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Walport, Mark J.
- Venue
- Nature Genetics
- Published
- 1998-05
- Volume
- 19
- Issue
- 1
- Pages
- 56-59
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2067217824
- Cited by
- 1,434
- References
- 21
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 22 · 2023: 18 · 2022: 27 · 2021: 29 · 2020: 20 · 2019: 39 · 2018: 29 · 2017: 37 · 2016: 27 · 2015: 36 · 2014: 47 · 2013: 39 · 2012: 62
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- C1q deficiency, glomerulonephritis, apoptotic bodies, systemic lupus erythematosus, classical complement pathway, autoimmunity, autoantibodies, efferocytosis, genetic background effects, immune deposits
- MeSH terms
- Animals, Antibodies, Antinuclear, Autoantigens, Crosses, Genetic, Glomerulonephritis, Homozygote, Kidney Glomerulus, Microscopy, Electron, Complement C1q, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.